ARTELO BIOSCIENCES, INC.
Qualité des données : 83%
ARTL
Nasdaq
Manufacturing
Chemicals
6,51 €
▼
0,33 €
(-4,82%)
Cap. Boursière: 5,32 M
Prix
6,51 €
Cap. Boursière
5,32 M
Fourchette du Jour
6,20 € — 6,84 €
Fourchette 52 Semaines
2,96 € — 85,80 €
Volume
185 790
Ouverture 6,47 €
Moyenne 50J / 200J
4,91 €
32,49% above
Moyenne 50J / 200J
14,68 €
55,65% below
Quick Summary
Points Clés
Negative free cash flow of -8,52 M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
N/A
Current Ratio0,38
Interest Coverage-58,78
Valorisation
PE (TTM)
-0,41
Au-dessus de la moyenne du secteur (-1,47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -0,4 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,5 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -12,88 M |
| ROE | N/A | ROA | -298,68% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -8,52 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,38 |
| Interest Coverage | -58,78 | Asset Turnover | N/A |
| Working Capital | -3,03 M | Tangible Book Value | -2,67 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,41 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -160,17% | ||
| Market Cap | 5,32 M | Enterprise Value | 5,32 M |
| Per Share | |||
| EPS (Diluted TTM) | -12,52 | Revenue / Share | N/A |
| FCF / Share | -10,43 | OCF / Share | -10,43 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 66,15% |
| SBC-Adj. FCF | -9,50 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -12,88 M | -9,83 M | -9,29 M | -10,08 M | -7,44 M |
| EPS (Diluted) | -12,52 | -3,05 | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -11,40 M | -10,11 M | -9,93 M | -10,29 M | -7,44 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 5,42 M | 5,99 M | 5,70 M | 4,32 M | 2,84 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 194 000,0 | — | 0,0 | 5 000,0 | — |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,80 M | 4,70 M | 13,04 M | 20,42 M | 12,64 M |
| Total Liabilities | 4,07 M | 1,84 M | 1,29 M | 1,02 M | 593 000,0 |
| Shareholders' Equity | -1,27 M | 2,86 M | 11,75 M | 19,40 M | 12,04 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 600 000,0 | — | — | 6,89 M | 6,63 M |
| Current Assets | 695 000,0 | 2,56 M | 10,98 M | 18,32 M | 10,32 M |
| Current Liabilities | 4,04 M | 1,77 M | 1,29 M | 998 000,0 | 526 000,0 |
{"event":"ticker_viewed","properties":{"ticker":"ARTL","listing_kind":"stock","pathname":"/stocks/artl","exchange":"Nasdaq","country":"US"}}